The evidence is promising, but it is preclinical
FREE telephone consultation AND
Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers Glc secretion, both in a glucose-dependent manner
Chicago Arthritis's overview of GLP-1, CJC-1295, AOD-9604, and related peptides lists nausea, headaches, and fluid retention as possible side effects and stresses that any peptide plan, especially a combined or "stacked" protocol, needs to be built and monitored by a knowledgeable physician (chicagoarthritis.com)
The amount depends on your desired concentration
If Approved, your kit ships to your doorstep